Clearside Biomedical Announces U.S. FDA Acceptance of Investigational New Drug Application for CLS-AX (axitinib injectable suspension) Administered in Suprachoroidal Space
Stock Information for Clearside Biomedical Inc.
Loading
Please wait while we load your information from QuoteMedia.